Our report on activities & financial performance throughout the year.
View an enhanced version of information about our annual meeting & matters to be voted upon.
Date: June 25, 2026
Time: 8:00 AM PT
Register By: June 24, 2026 at 5:00 PM ET
You must register to be eligible to participate in the meeting.
Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a clinical stage biotechnology company founded with the mission to improve patient outcomes by developing best-in-class therapies for the treatment of liver and viral diseases. Aligos applies its science driven approach and deep R&D expertise to advance its purpose-built pipeline of therapeutics for high unmet medical needs such as chronic hepatitis B virus infection, metabolic dysfunction-associated steatohepatitis (MASH), and coronaviruses.